PATRICK PURVES: Open Payments
NPI 1083216873 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 97 payments from 16 companies in 2025. Trend: 2023 $1,193 · 2024 $1,112 · 2025 $1,951
Food & beverage: $1,859Education: $92
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $394 |
| GENZYME CORPORATION | 10 | $226 |
| Regeneron Healthcare Solutions, Inc. | 8 | $211 |
| Janssen Biotech, Inc. | 9 | $203 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| Organon LLC | 12 | $171 |
| ABBVIE INC. | 9 | $144 |
| Botanix SB Inc | 4 | $90 |
| Galderma Laboratories, L.P. | 4 | $79 |
| PFIZER INC. | 4 | $74 |
Products named: DUPIXENT, Bimzelx, TREMFYA, COSENTYX, VTAMA, SOFDRA, NEMLUVIO, CIBINQO.
Industry payments across AZ — which companies pay providers there.
